Executives from Avella Specialty Pharmacy and mscripts, a leading mobile health provider, will present findings from a compelling new study on medication adherence at the 2015 Armada Specialty Pharmacy Summit on Thursday, May 7.
Avella Specialty Pharmacy has just released its third issue of Dispensing Excellence, a publication aimed at healthcare providers, nurses, medical assistants and their patients. The 28-page magazine is distributed by Avella in order to share insight on the latest trends and developments in the world of specialty drugs as well as the conditions they help manage.
Avella is proud to announce that it has achieved accreditation as a specialty pharmacy through Accreditation Commission for Health Care (ACHC).
Just days after the Food and Drug Administration approved Otezla, a new oral therapy to treat active psoriatic arthritis (PsA) in adult patients, Avella has announced that it is prepared to begin distributing the drug. At this time, Avella is one of a select number of pharmacies that are contracted by Celgene, the drug manufacturer, to dispense the product at launch.
Avella Specialty Pharmacy has announced that it has registered with the FDA as an Outsourcing Facility for sterile compounding as outlined in the recently enacted Drug Quality and Security Act (DQSA). Outsource Facilities must consent to greater federal oversight including more frequent inspections and are required to demonstrate their adherence to specific “good manufacturing practices.”
Avella Specialty Pharmacy, one of the nation’s largest and fastest growing independent specialty pharmacies, is proud to announce the addition of Rebecca M. Shanahan to its senior management team. Ms. Shanahan brings over two decades of highly successful leadership experience in the healthcare sector, as well as 5 years of service on Avella’s Board of Directors, to her new role as the Company’s Chief Executive Officer. John Musil, Pharm.D., FACA, the Company’s founder and CEO since inception, will continue to actively serve Avella as Chairman, focusing on long-term strategy and applying his unique combination of business expertise and pharmacist perspective as the Company’s ambassador to the clinical community.
